| Literature DB >> 29420985 |
Cynthia Ménard1, Eric Paulson2, Tufve Nyholm3, Patrick McLaughlin4, Gary Liney5, Piet Dirix6, Uulke A van der Heide7.
Abstract
The use of prostate MR imaging in radiotherapy continues to evolve. This article describes its current application in the selection of treatment regimens, integration in treatment planning or simulation, and assessment of response. An expert consensus statement from the annual MR in RT symposium is presented, as a list of 21 key quality indicators for the practice of MR imaging simulation in prostate cancer. Although imaging requirements generally follow PIRADSv2 guidelines, additional requirements specific to radiotherapy planning are described. MR imaging-only workflows and MR imaging-guided treatment systems are expected to replace conventional computed tomography-based practice, further adding specific requirements for MR imaging in radiotherapy.Entities:
Keywords: Brachytherapy; Image-guidance; MR imaging; Prostate cancer; Radiotherapy
Mesh:
Year: 2017 PMID: 29420985 DOI: 10.1016/j.rcl.2017.10.012
Source DB: PubMed Journal: Radiol Clin North Am ISSN: 0033-8389 Impact factor: 2.303